Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Comparative Study

Clinical Trial

Multicenter Study

Letter

Review

Evaluation Study

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2023

2018

2017

2016

2012

2011

2010

2007

2005

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Ioxaglic Acid""[mesh_terms]

13 Results

Searching titles within these results

Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.

Rafaela Andrade Penalva Freitas, Luis Fernando Tanajura, Roxana Mehran, Daniel Chamié, Aurea Chaves, Marinella Centemero, Sergio Braga, Ricardo Costa, Davide Cao, Amanda Sousa, Fausto Feres, J Ribamar Costa

The Journal of invasive cardiology 2023;35(6):E281-E290

Free Full Text

Abstract

Contrast-enhanced CT imaging as a non-destructive tool for ex vivo examination of the biochemical content and structure of the human meniscus.

Daniel J Oh, Benjamin A Lakin, Rachel C Stewart, Martin Wiewiorski, Jonathan D Freedman, Mark W Grinstaff, Brian D Snyder

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2017;35(5):1018-1028

Free Full Text

Abstract

Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen.

Shilpa Vishwanath, Fuad M Baroody, Mohamad R Chaaban, Marcella deTineo, Kenneth H Lasser, Elliot C Lasser, Robert M Naclerio

The Journal of allergy and clinical immunology 2011;128(1):219-21

Full Text

Accuracy of iodine quantification using dual energy CT in latest generation dual source and dual layer CT.

Gert Jan Pelgrim, Robbert W van Hamersvelt, Martin J Willemink, Bernhard T Schmidt, Thomas Flohr, Arnold Schilham, Julien Milles, Matthijs Oudkerk, Tim Leiner, Rozemarijn Vliegenthart

European radiology 2018;27(9):3904-3912

Free Full Text

Abstract

N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.

V O Gomes, C E Poli de Figueredo, P Caramori, R Lasevitch, L C Bodanese, A Araújo, A P Röedel, A P Caramori, F S Brito, H G Bezerra, P Nery, A Brizolara

Heart (British Cardiac Society) 2005;91(6):774-8

Free Full Text

Abstract

The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.

Binita Shah, Jeffrey S Berger, Nicole Allen, Yu Guo, Steven P Sedlis, Jinfeng Xu, Adriana Perez, Michael Attubato, James Slater, Frederick Feit

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2017;88(5):727-737

Free Full Text

Abstract

Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.

Emre Aslanger, Bora Uslu, Cansu Akdeniz, Nihat Polat, Yasar Cizgici, Huseyin Oflaz

Coronary artery disease 2012;23(4):265-70

Full Text

Abstract

Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.

Denis Angoulvant, Michel Cucherat, Gilles Rioufol, Gérard Finet, Jacques Beaune, Didier Revel, Maurice Laville, Michel Ovize, Xavier André-Fouët

Archives of cardiovascular diseases 2010;102(11):761-7

Free Full Text

Abstract

Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

Roxana Mehran, Eugenia Nikolsky, Ajay J Kirtane, Adriano Caixeta, S Chiu Wong, Paul S Teirstein, William E Downey, Wayne B Batchelor, Peter J Casterella, Young-Hak Kim, Martin Fahy, George D Dangas

JACC. Cardiovascular interventions 2010;2(5):415-21

Free Full Text

Abstract

Comparative tolerability of contrast media used for coronary interventions.

Enrique Esplugas, Angel Cequier, Joan A Gomez-Hospital, Bruno García Del Blanco, Francisco Jara

Drug safety 2003;25(15):1079-98

Full Text

Abstract

Contrast-enhanced CT facilitates rapid, non-destructive assessment of cartilage and bone properties of the human metacarpal.

B A Lakin, D J Ellis, J S Shelofsky, J D Freedman, M W Grinstaff, B D Snyder

Osteoarthritis and cartilage 2016;23(12):2158-2166

Free Full Text

Abstract

A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.

Pascal Auquier, Sophie Morange, Yvon Berland, Anderson Loundoun, Bertrand Dussol

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;21(8):2120-6

Full Text

Abstract

Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study.

Per Liss, Hampus Eklöf, Olof Hellberg, Anders Hägg, Annika Boström-Ardin, Anne-Marie Löfberg, Ulf Olsson, Per Orndahl, Helena Nilsson, Peter Hansell, Lars-Gunnar Eriksson, David Bergqvist, Richard Nyman

Journal of vascular and interventional radiology : JVIR 2005;16(1):57-65

Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Ioxaglic Acid""[mesh_terms]

Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.

Contrast-enhanced CT imaging as a non-destructive tool for ex vivo examination of the biochemical content and structure of the human meniscus.

Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen.

Accuracy of iodine quantification using dual energy CT in latest generation dual source and dual layer CT.

N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.

The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.

Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.

Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.

Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

Comparative tolerability of contrast media used for coronary interventions.

Contrast-enhanced CT facilitates rapid, non-destructive assessment of cartilage and bone properties of the human metacarpal.

A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.

Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study.

Results for
""Ioxaglic Acid""[mesh_terms]